Trial Profile
A Randomized Phase II Study Evaluating Different Schedules of Nab-Paclitaxel in Metastatic Breast Cancer (SNAP Trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- Acronyms SNAP; SNAP Trial
- 30 May 2023 Status changed from active, no longer recruiting to completed.
- 17 May 2023 This trial has been completed in Ireland, according to European Clinical Trials Database record.
- 28 Apr 2022 This trial has been completed in Belgium, according to European Clinical Trials Database record.